Vemma and Verve each underwent the highest standard of clinical research — four independent, randomized, double-blind, placebo-controlled studies — in order to demonstrate the life-changing benefits they provide for enhanced immune function, inflammation, reduced inflammation, and antioxidant absorption.*

CLINICAL STUDIES FOR VEMMA AND VERVE

People taking Vemma or Verve for 30 days demonstrated:

·Significant improvements in immune markers*

·Lowering of C-Reactive Protein (CRP) an important marker for inflammation*

·Superior antioxidant absorption*

Vemma Bottle
Double Checkmark

The benefits of Vemma have been backed by two distinct scientific clinical studies

The Vemma formula was the focus of two randomized, double-blind, placebo-controlled clinical trials that helped illustrate the potent antioxidant properties and high bioavailability of this groundbreaking supplement.*

The Science Of

Bode Strong Packet

Utilizing the research behind the Vemma formula, we developed Strong, which gives you the option to take your immune-boosting protection with you anywhere.

Strong uses the clinically studied Vemma formula and takes it to the next level. Strong provides you with the exact same vitamins, minerals, and phytonutrients found in Vemma and adds potent ingredients like maca, curcumin, and silica to make it even more nutritious.

STRONG IS QUITE POSSIBLY THE MOST POWERFUL LIQUID ANTIOXIDANT AVAILABLE ANYWHERE.

VEMMA STUDIES

BIOAVAILABILITY and ANTIOXIDANT STUDY: These studies were designed to determine the overall bioavailability (body readiness) and antioxidant effect. Participants were separated into two groups, placebo and product to be tested (Vemma or Verve). Before the products were consumed, each participant’s blood was measured. Then, participants either received a single dose of the product to be tested or a placebo. Blood samples were collected and evaluated.

Vemma ORAC Chart

The antioxidant amounts indicated show how Vemma is highly bioavailable and antioxidant rich compared to the placebo.*

Read Full Study (PDF)

C-REACTIVE PROTEIN LEVELS (CRP) STUDY: The purpose of these independent, randomized, double-blind, placebo-controlled studies was to evaluate how Vemma or Verve enhanced immune function and well-being in humans.* Participants were randomly divided into two groups and received the product to be tested or a placebo each morning for 30 days.

Participants were randomly divided into two groups and received a serving of Vemma or a placebo each morning for 30 days. After the 30-day evaluation, the study showed those who consumed Vemma had significantly lowered their levels of C-Reactive Protein (CRP.)*

Read Full Study (PDF)

Vemma CRP Chart

The Vemma immunity study and Vemma bioavailability study are published in two reputable journals, the Journal of Medicinal Food and Journal of Agricultural and Food Chemistry, respectively.

verve Can
Double Checkmark

Verve has been clinically validated in two separate studies

Verve was subjected to the highest standard of clinical testing. The Immunity Study showed those who consumed a can of Verve for 30 days resulted in a 24% decrease in C-Reactive Protein.* The Bioavailability Study showed how Verve is antioxidant-rich and had maximum absorption levels in Vitamins A, B2, B5, C, E, selenium, and antioxidants from mangosteen.*

BIOAVAILABILITY and ANTIOXIDANT STUDY: These studies were designed to determine the overall bioavailability (body readiness) and antioxidant effect. Participants were separated into two groups, placebo and product to be tested (Vemma or Verve). Before the products were consumed, each participant’s blood was measured. Then, participants either received a single dose of the product to be tested or a placebo. Blood samples were collected and evaluated.

Verve ORAC Chart

The antioxidant amounts show how Verve is highly bioavailable and antioxidant rich in vitamins A, C, and E, and selenium compared to the placebo group.*

Read Full Study (PDF)

Protect your 37 trillion cells with Verve!*

IMMUNITY STUDY: Participants were randomly divided into two groups and received a serving of Verve or a placebo each morning for 30 days. After the 30-day evaluation, the study showed those who consumed Verve received immune support as indicated by their lower levels of C-Reactive Protein (CRP).*

After the 30-day evaluation, the study showed those who consumed a serving of Verve had a 24% decrease in C-Reactive Protein (CRP).

Read Full Study (PDF)

Verve Immunity Chart

The science behind all Vemma and Verve products is our highest priority.

To ensure the best quality we:

·Source only the highest quality raw ingredients

·Incorporate the newest advances in nutrition and technology

·Adhere to extensive manufacturing and testing standards

·Complete an extensive quality control process before every product is released for purchase

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.